Prosecution Insights
Last updated: November 15, 2026

The Catholic University Of America

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

The Catholic University Of America operates a company patent portfolio within the Biotechnology & Pharmaceuticals technology area. The current prosecution landscape features 1 pending office action. This action is handled by 1 distinct examiner, BUCKMASTER, MARLENE VRENI, who is the sole examiner identified in the portfolio. The activity is localized in a distinct art unit, which points to a concentrated technical scope for the university's applications. BUCKMASTER, MARLENE VRENI is the busiest examiner, overseeing the busiest examiner pending action.

For a practitioner, the presence of 1 pending office action suggests a focused stage of portfolio development. Since a distinct examiner and a distinct art unit are involved, the prosecution strategy can be optimized for the specific examination environment of BUCKMASTER, MARLENE VRENI. The fact that the busiest examiner pending action is handled by this individual means that all current USPTO interactions are centralized. This streamlined profile in the Biotechnology & Pharmaceuticals sector facilitates direct management of the university's patent assets and pharmaceutical claims.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BUCKMASTER, MARLENE VRENI 1 28.1% +74.3%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17548629 UNIVERSAL BACTERIOPHAGE T4 NANOPARTICLE PLATFORM TO DESIGN MULTIPLEX SARS-COV-2 VACCINE CANDIDATES BY CRISPR ENGINEERING BUCKMASTER, MARLENE VRENI —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17548629 UNIVERSAL BACTERIOPHAGE T4 NANOPARTICLE PLATFORM TO DESIGN MULTIPLEX SARS-COV-2 VACCINE CANDIDATES BY CRISPR ENGINEERING BUCKMASTER, MARLENE VRENI —

Top Art Units

Art UnitApps
1672 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17548629 UNIVERSAL BACTERIOPHAGE T4 NANOPARTICLE PLATFORM TO DESIGN MULTIPLEX SARS-COV-2 VACCINE CANDIDATES BY CRISPR ENGINEERING BUCKMASTER, MARLENE VRENI 1672 §103Other Final Rejection — Pending Dec 13, 2021

Managing The Catholic University Of America's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does The Catholic University Of America have?

The Catholic University Of America has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most The Catholic University Of America applications?

Marlene Vreni Buckmaster has the most, with 1 of The Catholic University Of America's pending office actions.

What technology area are The Catholic University Of America's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month